Genic Co. Ltd Capital Reinvestment Ratio
Genic Co. Ltd capital reinvestment ratio. Genic Co. Ltd (123330) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩7.70 Billion) in capital expenditures (₩958.13 Million). See Genic Co. Ltd (123330) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Genic Co. Ltd (2012–2025)
Capital reinvestment ratio of Genic Co. Ltd from 2012 to 2025. This chart tracks Genic Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. See financial flexibility index of Genic Co. Ltd to measure the company's free cash flow as a share of total liabilities.
Genic Co. Ltd Capital Reinvestment Ratio by Year (2012–2025)
Genic Co. Ltd capital reinvestment ratio by year from 2012 to 2025. For the full cash flow conversion analysis, see Genic Co. Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | ₩20.65 Billion | ₩2.68 Billion | ▼ -97.9% |
| 2024 | 6.06x | ₩272.46 Million | ₩1.65 Billion | ▼ -24.2% |
| 2022 | 8.00x | ₩177.94 Million | ₩1.42 Billion | ▲ +3984.9% |
| 2021 | 0.20x | ₩3.32 Billion | ₩650.83 Million | ▼ -94.6% |
| 2020 | 3.62x | ₩212.66 Million | ₩769.27 Million | ▲ +499.4% |
| 2019 | 0.60x | ₩1.38 Billion | ₩830.95 Million | ▼ -86.5% |
| 2016 | 4.48x | ₩1.93 Billion | ₩8.63 Billion | ▲ +20.7% |
| 2015 | 3.71x | ₩3.63 Billion | ₩13.48 Billion | ▲ +89.2% |
| 2014 | 1.96x | ₩5.80 Billion | ₩11.39 Billion | ▼ -17.0% |
| 2013 | 2.36x | ₩3.68 Billion | ₩8.69 Billion | ▲ +130.9% |
| 2012 | 1.02x | ₩4.31 Billion | ₩4.41 Billion | — |